Literature DB >> 32399999

How to Manage Febrile Neutropenia During the COVID Pandemic?

Saber Boutayeb1, Ibrahim El Ghissassi1, Hind Mrabti1, Hassan Errihani1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32399999      PMCID： PMC7418344          DOI： 10.1634/theoncologist.2020-0285

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  5 in total

Review 1.  Predictive factors for poor prognosis febrile neutropenia.

Authors:  Shin Ahn; Yoon-Seon Lee
Journal:  Curr Opin Oncol       Date:  2012-07       Impact factor: 3.645

Review 2.  Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  Matthias Kochanek; E Schalk; M von Bergwelt-Baildon; G Beutel; D Buchheidt; M Hentrich; L Henze; M Kiehl; T Liebregts; M von Lilienfeld-Toal; A Classen; S Mellinghoff; O Penack; C Piepel; B Böll
Journal:  Ann Hematol       Date:  2019-02-22       Impact factor: 3.673

Review 3.  Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.

Authors:  Liat Vidal; Itsik Ben Dor; Mical Paul; Noa Eliakim-Raz; Ellisheva Pokroy; Karla Soares-Weiser; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2013-10-09

Review 4.  A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.

Authors:  Humaid O Al-Shamsi; Waleed Alhazzani; Ahmad Alhuraiji; Eric A Coomes; Roy F Chemaly; Meshari Almuhanna; Robert A Wolff; Nuhad K Ibrahim; Melvin L K Chua; Sebastien J Hotte; Brandon M Meyers; Tarek Elfiki; Giuseppe Curigliano; Cathy Eng; Axel Grothey; Conghua Xie
Journal:  Oncologist       Date:  2020-04-27

5.  Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

Authors:  Wenhua Liang; Weijie Guan; Ruchong Chen; Wei Wang; Jianfu Li; Ke Xu; Caichen Li; Qing Ai; Weixiang Lu; Hengrui Liang; Shiyue Li; Jianxing He
Journal:  Lancet Oncol       Date:  2020-02-14       Impact factor: 41.316
  5 in total
  1 in total

1.  In Reply.

Authors:  Eric A Coomes; Humaid O Al-Shamsi; Brandon M Meyers; Waleed Alhazzani; Ahmad Alhuraiji; Roy F Chemaly; Meshari Almuhanna; Robert A Wolff; Nuhad K Ibrahim; Melvin L K Chua; Sebastien J Hotte; Tarek Elfiki; Giuseppe Curigliano; Cathy Eng; Axel Grothey; Conghua Xie
Journal:  Oncologist       Date:  2020-05-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.